Antisenescence activity of G9a inhibitor BIX01294 on human bone marrow mesenchymal stromal cells

Alterations in epigenomic patterns are associated with diverse physiological functions and pathological mechanisms causing aging-related diseases, such as degenerative disorders and cancers. We investigated the senescent effects of BIX01294, a G9a (histone methyltransferase) inhibitor, in human bone marrow mesenchymal stromal cells (hBM-MSCs). We determined the optimal dose and time of BIX01294 treatment in hBM-MSCs to be 1 μM and 12 h, respectively. Under these conditions, the expression of the antisenescent genes TERT, bFGF, VEGF, and Oct-4 increased, whereas the expression of the senescent factors p16, p21, and p53 decreased. The number of β-galactosidase-positive cells decreased significantly, and the rates of migration and cellular protection against oxidative damage increased in BIX01294-treated MSCs. These data indicate that an optimized dose of BIX01294 may improve the potency and senescence of stem cells, which may improve the efficacy of stem cell therapy.

PDF

___

Baumann K (2012). Stem cells: An ageing decline. Nat Rev Mol Cell Biol 13: 681.
Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W (2010). DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54–63.
Caplan AI, Dennis JE (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076–1084.
Chang Y, Zhang X, Horton JR, Upadhyay AK, Spannhoff A, Liu J, Snyder JP, Bedford MT, Cheng X (2009). Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat Struct Mol Biol 16: 312–317.
Cho GW, Kang BY, Kim SH (2010a). Human angiogenin presents neuroprotective and migration effects in neuroblastoma cells. Mol Cell Biochem 340: 133–141.
Cho GW, Noh MY, Kim HY, Koh SH, Kim KS, Kim SH (2010b). Bone marrow-derived stromal cells from amyotrophic lateral sclerosis patients have diminished stem cell capacity. Stem Cells Dev 19: 1035–1042.
Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M, Tsunoda T, Field HI, Neal DE, Ponder BA et al. (2011). Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 13: 676–684.
Choi MR, In YH, Park J, Park T, Jung KH, Chai JC, Chung MK, Lee YS, Chai YG (2012). Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Exp Mol Med 44: 503–512.
Go SI, Ko GH, Lee WS, Kim RB, Lee JH, Jeong SH, Lee YJ, Hong SC, Ha WS (2015). CD44 variant 9 serves as a poor prognostic marker in early gastric cancer, but not in advanced gastric cancer. Cancer Res Treat doi: 10.4143/crt.2014.227.
Ho AD, Wagner W, Mahlknecht U (2005). Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine. EMBO Rep 6 Spec No: S35–38.
Hong JS, Kim JO, Lee H, Bae IK, Jeong SH, Lee K (2015). Characteristics of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Korea. Infect Chemother 47: 33–40.
Huang J, Dorsey J, Chuikov S, Perez-Burgos L, Zhang X, Jenuwein T, Reinberg D, Berger SL (2010). G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem 285: 9636–9641.
Jeong SG, Ohn T, Kim SH, Cho GW (2013). Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells. Neurosci Lett 554: 22–27.
Jeong SH, Choi KS, Lee KY, Kim EJ, Kim YS, Joo EJ (2015). Association between the dopamine transporter gene (DAT1) and attention deficit hyperactivity disorder-related traits in healthy adults. Psychiatr Genet 25: 119–126.
Johnson AA, Akman K, Calimport SR, Wuttke D, Stolzing A, de Magalhaes JP (2012). The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res 15: 483–494.
Kang H, Jung S, Jeong S, Kim G, Lee K (2015). Polymer-metal hybrid transparent electrodes for flexible electronics. Nat Commun 6: 6503.
Kim HJ, Joe Y, Yu JK, Chen Y, Jeong SO, Mani N, Cho GJ, Pae HO, Ryter SW, Chung HT (2015). Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway. Biochim Biophys Acta 1852: 1550– 1559.
Kim SJ, Yun YJ, Kim KW, Chae C, Jeong S, Kang Y, Choi SY, Lee SS, Choi S (2015). Superior lithium storage performance using sequentially stacked MnO2 /reduced graphene oxide composite electrodes. ChemSusChem 8: 1484–1491.
Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J (2011). Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 10: 457–468.
Kubicek S, O’Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML, Rea S, Mechtler K, Kowalski JA, Homon CA et al (2007). Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 25: 473–481.
Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA (2012). Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med 1: 142–149.
Meirelles Lda S, Fontes AM, Covas DT, Caplan AI (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20: 419–427.
Mezentseva NV, Yang J, Kaur K, Iaffaldano G, Remond MC, Eisenberg CA, Eisenberg LM (2013). The histone methyltransferase inhibitor BIX01294 enhances the cardiac potential of bone marrow cells. Stem Cells Dev 22: 654–667.
Nagai A, Kim WK, Lee HJ, Jeong HS, Kim KS, Hong SH, Park IH, Kim SU (2007). Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS One 2: e1272.
Oh YS, Jeong SG, Cho GW (2015). Anti-senescence effects of DNA methyltransferase inhibitor RG108 in human bone marrow mesenchymal stromal cells. Biotechnol Appl Biochem doi: 10.1002/bab.1393.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147.
Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL (2007). Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447: 725–729.
Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3: 568–574.
So AY, Jung JW, Lee S, Kim HS, Kang KS (2011). DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. PLoS One 6: e19503.
Takahashi A, Imai Y, Yamakoshi K, Kuninaka S, Ohtani N, Yoshimoto S, Hori S, Tachibana M, Anderton E, Takeuchi T et al (2012). DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. Mol Cell 45: 123–131.
Tran VT, Zhou H, Lee S, Hong SC, Kim J, Jeong SY, Lee J (2015). Magnetic-assembly mechanism of superparamagneto-plasmonic nanoparticles on a charged surface. ACS Appl Mater Interfaces 7: 8650–8658.
Yang HK, Lee JH, Choi IY, Kwon HS, Shin JA, Jeong SH, Lee SH, Cho JH, Son HY, Yoon KH (2015). The insulin resistance but not the insulin secretion parameters have changed in the Korean population during the last decade. Diabetes Metab J 39: 117– 125.
Yu H, Lin Q, Wang Y, He Y, Fu S, Jiang H, Yu Y, Sun S, Chen Y, Shou J et al (2013). Inhibition of H3K9 methyltransferases G9a/GLP prevents ototoxicity and ongoing hair cell death. Cell Death Dis 4: e506.
Yuan Y, Tang AJ, Castoreno AB, Kuo SY, Wang Q, Kuballa P, Xavier R, Shamji AF, Schreiber SL, Wagner BK (2013). Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. Cell Death Dis 4: e690